In the Media: Clinicians Embracing New Depression Drug Esketamine With ‘Enthusiastic Caution’

STAT

Dr. Robert Meisner offers feedback on the FDA’s approval of a new ketamine product.

Media Requests

Journalist or member of the media?
We are available 24/7 for media requests.